SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-032448
Filing Date
2019-02-08
Accepted
2019-02-08 17:22:31
Documents
5
Period of Report
2019-02-08

Document Format Files

Seq Description Document Type Size
1 6-K d698371d6k.htm 6-K 15735
2 EX-1.1 d698371dex11.htm EX-1.1 184962
3 EX-5.1 d698371dex51.htm EX-5.1 22743
4 GRAPHIC g69837101.jpg GRAPHIC 27492
5 GRAPHIC g69837102.jpg GRAPHIC 6204
  Complete submission text file 0001193125-19-032448.txt   271079
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 19581072
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1